Medicare Enrolled

Dr. Joseph Gathe, M.D.

Infectious Disease · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
4900 FANNIN ST, Houston, TX 77004
7135269821
In practice since 2005 (20 years)
NPI: 1366436263 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gathe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gathe? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gathe

Dr. Joseph Gathe is an infectious disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Gathe performed 2,986 Medicare services across 860 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gathe received a total of $619,842 from 48 pharmaceutical and/or device companies across 1459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gathe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 12% volume in TX$ $619,842 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,986
Medicare services
Top 12% in TX for infectious disease
860
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~149 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity1,050$63$146
Hospital follow-up visit, high complexity829$95$217
Office visit, established patient (30-39 min)452$86$158
Office visit, established patient, complex (40-54 min)191$137$250
Hospital follow-up visit, low complexity163$40$108
Initial hospital admission, high complexity126$127$338
Office visit, established patient (20-29 min)86$70$125
Initial hospital admission, moderate complexity61$102$272
Office visit, established patient (10-19 min)16$46$68
New patient office visit, complex (60-74 min)12$163$318
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$619,842
Total received (2018-2024)
Avg $88,549/year across 7 years
Top 1% in TX for infectious disease
48
Companies
1,459
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$604,082 (97.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,895 (2.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,866 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$135,721
2023
$135,085
2022
$75,051
2021
$29,526
2020
$55,888
2019
$114,386
2018
$74,186

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Products, LP
$413,074
Gilead Sciences, Inc.
$97,939
EMD Serono, Inc.
$41,371
ABBVIE INC.
$24,777
La Jolla Pharmaceutical Company
$12,200
AbbVie Inc.
$6,501
AbbVie, Inc.
$5,649
TETRAPHASE PHARMACEUTICALS, INC.
$4,554
Theratechnologies Inc.
$3,260
Janssen Biotech, Inc.
$2,116
ViiV Healthcare Company
$1,491
BeiGene, Ltd.
$1,100
Napo Pharmaceuticals Inc
$1,053
Merck Sharp & Dohme Corporation
$765
Paratek Pharmaceuticals, Inc.
$666
Shionogi Inc
$655
Melinta Therapeutics, Inc.
$400
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$346
Allergan Inc.
$307
Merck Sharp & Dohme LLC
$257
Axsome Therapeutics, Inc.
$207
Amarin Pharma Inc.
$175
Allergan, Inc.
$148
ARBOR PHARMACEUTICALS, INC.
$115
Lilly USA, LLC
$76
Ferring Pharmaceuticals Inc.
$68
Genentech USA, Inc.
$58
Antares Pharma, Inc.
$50
Novo Nordisk Inc
$43
Janssen Pharmaceuticals, Inc
$37
Pharming Healthcare, Inc.
$32
Tolmar, Inc.
$32
Shire North American Group Inc
$32
Cumberland Pharmaceuticals, Inc.
$31
Esperion Therapeutics, Inc.
$30
Invivyd Inc
$29
Verity Pharmaceuticals Inc.
$24
ITI, Inc.
$22
Aytu Bioscience, Inc
$22
MAYNE PHARMA INC.
$19
Insmed, Inc.
$18
Horizon Therapeutics plc
$16
Arbor Pharmaceuticals, Inc.
$15
Ortho Dermatologics, a division of Bausch Health US, LLC
$15
Purdue Pharma L.P.
$14
Nabriva Therapeutics, plc
$13
Mayne Pharma Inc.
$11
Dynavax Technologies Corporation
$10
Top 3 companies account for 89.1% of total payments
Associated products mentioned in payments ›
APRETUDE · AVYCAZ · Arikayce · Baxdela · Bidil · Biktarvy · CABENUVA · CAPLYTA · CREON · DALVANCE · DELSTRIGO · DORYX · DOVATO · EGRIFTA · EGRIFTA SV · Edarbi · Edarbyclor · Fetroja · GATTEX · GIAPREZA · Heplisav-B · ISENTRESS · JARDIANCE · JATENZO · JULUCA · LINZESS · MAVYRET · Mavyret · Mytesi · NEXLETOL · NOCDURNA · NUZYRA · Natesto · PEMGARDA · PIFELTRO · PREZCOBIX · RAYOS · REBYOTA · RELISTOR · RUCONEST · SEROSTIM · SYMPROIC · SYMTUZA · Serostim · Sunosi · Symtuza · TEFLARO · TROGARZO · TRULICITY · Tlando · VIBATIV · VIBERZI · VRAYLAR · Vabomere · Vascepa · Veklury · Wegovy · XACDURO · XARELTO · XERAVA · XERESE · XIFAXAN · XIFAXANIBSD · XYOSTED · Xenleta · Xerava · Xofluza
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for infectious disease in TX.

Equivalent to $20,758 per 100 Medicare services performed
Looking for a infectious disease in Houston?
Compare infectious diseases in the Houston area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious Diseases within 10 mi
147
Per 100K population
3.1
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gathe is a clinical cardiology specialist, with above-average Medicare volume (top 12% in TX), and high industry engagement (speaking/promotional, top 1%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gathe experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Gathe performed 1,050 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gathe receive payments from pharmaceutical companies?
Yes. Dr. Gathe received a total of $619,842 from 48 companies across 1,459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gathe's costs compare to other infectious diseases in Houston?
Dr. Gathe's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gathe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →